eISSN 2508-3589
pISSN 2508-1926

Table. 1.

Table. 1.

Baseline characteristics of included patients with diabetes

Variable DME (n = 30) No DME (n = 23) p-value
Age (years) 59.1 ± 10.7 53.4 ± 9.9 0.050*
Male (sex) 20 (67) 9 (39) 0.046
HbA1c (%) 8.0 ± 1.8 9.1 ± 2.2 0.055*
Medications
ACEI/ARB 11 (37) 10 (43) 0.716
β-Blocker 5 (17) 2 (9) 0.353
CCB 11 (37) 8 (35) 0.770
Diuretics 4 (13) 4 (17) 0.740
Statins 13 (43) 13 (57) 0.414
Antidiabetic medications
Metformin 18 (60) 15 (65) 0.870
Sulfonylurea 10 (33) 12 (52) 0.202
SGLT-2 inhibitor 2 (7) 1 (4) 0.683
DPP-4 inhibitor 15 (50) 14 (61) 0.529
Thiazolidinedione 2 (7) 4 (17) 0.246
Insulin 10 (33) 12 (52) 0.202
Systolic BP (mmHg) 136.3 ± 21.6 134.1 ± 20.5 0.781*
Diastolic BP (mmHg) 75.6 ± 11.9 79.6 ± 13.3 0.285*
NPDR:PDR 18:12 8:15 0.069

Values are presented as mean ± standard deviation or number (%) unless otherwise indicated.

DME = diabetic macular edema; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; β-blocker = β-adrenergic receptor-blocker; CCB = calcium channel blocker; SGLT-2 = sodium glucose cotransporter-2; DPP-4 = dipeptidyl peptidase-4; BP = blood pressure; NPDR = non-proliferative diabetic retinopathy; PDR = proliferative diabetic retinopathy.

Mann-Whitney U test;

chi-square test.

J Retin 2019;4:69-76 https://doi.org/10.21561/jor.2019.4.2.69
© 2019 J Retin